Armata Pharmaceuticals (ARMP) Amortization - Intangibles (2013)
Armata Pharmaceuticals (ARMP) reported Amortization - Intangibles of -$24000.0 for Q4 2013, down 204.35% sequentially from $23000.0 in Q3 2013.
Armata Pharmaceuticals (ARMP) Amortization - Intangibles (2013) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 1 years of Amortization - Intangibles data on file, last reported at -$24000.0 in Q4 2013.
- For the quarter ending Q4 2013, Amortization - Intangibles changed N/A year-over-year to -$24000.0; the trailing twelve-month figure through Dec 2014 stood at -$1000.0 (changed N/A YoY), and the FY2013 full-year result was $2.6 million, changed N/A from the prior year.
- Amortization - Intangibles fell to -$24000.0 in Q4 2013, from $23000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $23000.0 in Q3 2013 to a low of -$24000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -24,000.00 |
| Sep 30, 2013 | 23,000.00 |